RxDoctor Payments Data

Douglas Gohn, MD

Clinical Cardiac Electrophysiology · Lancaster, PANPI 1669449294

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 3 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Akcea Therapeutics, Inc. accounts for 71.2% of it on its own, with 2 other manufacturers making up the rest. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in PA, where the typical reported total is $15,643.

$188in general payments, 2019–2025

Across 3 payments — averaging $62.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Akcea Therapeutics, Inc.$134
  • Impulse Dynamics (USA) Inc.$34
  • Abbott$20
$6,193in research payments, 2019–2025

Across 1 payment — averaging $6193.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$6K

What the payments were for

  • Food & beverage$188100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$188 in reported general payments places this provider in the 0th percentile of 201 clinical cardiac electrophysiology providers in Pennsylvania.

See all clinical cardiac electrophysiology providers in Pennsylvania →

Medicare billing

Part B allowed, 2024
$310,214
Medicare patients
3,143
Services billed
6,636

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VyndamaxTafamidis19$418,818
EliquisApixaban227$219,279
MultaqDronedarone Hcl88$81,536
XareltoRivaroxaban44$47,418
Metoprolol Succinate149$1,897
Flecainide Acetate39$1,009
Amiodarone Hcl109$1,004
Midodrine Hcl14$696
Potassium Chloride21$585
Bisoprolol Fumarate55$484
SotalolSotalol Hcl42$447
Diltiazem 24hr Er (Cd)Diltiazem Hcl31$418
Losartan Potassium50$384
Atorvastatin Calcium33$280
Warfarin Sodium52$266

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Lancaster

See the full list for Pennsylvania →

Where these figures come from

Is this you, or does something look wrong? →